Gastrin-mediated activation of cyclin D1 transcription involves β-catenin and CREB pathways in gastric cancer cells

被引:90
作者
Pradeep, A
Sharma, C
Sathyanarayana, P
Albanese, C
Fleming, JV
Wang, TC
Wolfe, MM
Baker, KM
Pestell, RG
Rana, B [1 ]
机构
[1] Texas A&M Univ Syst Hlth Sci Ctr, Coll Med, Div Mol Cardiol, Temple, TX 76504 USA
[2] Georgetown Univ, Med Ctr, Lombardi Canc Ctr, Washington, DC 20057 USA
[3] Univ Massachusetts, Sch Med, Gastrointestinal Div, Worcester, MA 01605 USA
[4] Boston Med Ctr, Gastroenterol Sect, Boston, MA 02118 USA
关键词
cyclin D1; Wnt signaling; transcription; gastrin (G-17); CREB;
D O I
10.1038/sj.onc.1207454
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gastrin and its precursors promote proliferation in different gastrointestinal cells. Since mature, amidated gastrin (G-17) can induce cyclin D1, we determined whether G-17-mediated induction of cyclin D1 transcription involved Wnt signaling and CRE-binding protein (CREB) pathways. Our studies indicate that G-17 induces protein, mRNA expression and transcription of the G(1)-specific marker cyclin D1, in the gastric adenocarcinoma cell line AGSE (expressing the gastrin/cholecystokinin B receptor). This was associated with an increase in steady-state levels of total and nonphospho beta-catenin and its nuclear translocation, indicating the activation of the Wnt-signaling pathway. In addition, G-17-mediated increase in cyclin D1 transcription was significantly attenuated by axin or dominant-negative (dn) T-cell factor 4(TCF4), suggesting crosstalk of G-17 with the Wnt-signaling pathway. Mutational analysis indicated that this effect was mediated through the cyclic AMP response element (CRE) (predominantly) and the TCF sites in the cyclin D1 promoter, which was also inhibited by dnCREB. Furthermore, G-17 stimulation resulted in increased CRE-responsive reporter activity and CREB phosphorylation, indicating an activation of CREB. Chromatin immunoprecipitation studies revealed a G-17-mediated increase in the interaction of beta-catenin with cyclin D1 CRE, which was attenuated by dnTCF4 and dnCREB. These results indicate that G-17 induces cyclin D1 transcription, via the activation of beta-catenin and CREB pathways.
引用
收藏
页码:3689 / 3699
页数:11
相关论文
共 66 条
[1]  
Arato-Ohshima T, 1999, INT J CANCER, V83, P387, DOI 10.1002/(SICI)1097-0215(19991029)83:3<387::AID-IJC15>3.0.CO
[2]  
2-O
[3]   Negative regulation of mixed lineage kinase 3 by protein kinase B/AKT leads to cell survival [J].
Barthwal, MK ;
Sathyanarayana, P ;
Kundu, CN ;
Rana, B ;
Pradeep, A ;
Sharma, C ;
Woodgett, JR ;
Rana, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (06) :3897-3902
[4]   Linking colorectal cancer to Wnt signaling [J].
Bienz, M ;
Clevers, H .
CELL, 2000, 103 (02) :311-320
[5]   Gastrin mediated cholecystokinin-2 receptor activation induces loss of cell adhesion and scattering in epithelial MDCK cells [J].
Bierkamp, C ;
Kowalski-Chauvel, A ;
Dehez, S ;
Fourmy, D ;
Pradayrol, L ;
Seva, C .
ONCOGENE, 2002, 21 (50) :7656-7670
[6]   c-Myc target gene specificity is determined by a post-DNA-binding mechanism [J].
Boyd, KE ;
Wells, J ;
Gutman, J ;
Bartley, SM ;
Farnham, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13887-13892
[7]   The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3β and cAMP-responsive element-binding protein-dependent pathways [J].
D'Amico, M ;
Hulit, J ;
Amanatullah, DF ;
Zafonte, BT ;
Albanese, C ;
Bouzahzah, B ;
Fu, MF ;
Augenlicht, LH ;
Donehower, LA ;
Takemaru, KI ;
Moon, RT ;
Davis, R ;
Lisanti, MP ;
Shtutman, M ;
Zhurinsky, J ;
Ben-Ze'ev, A ;
Troussard, AA ;
Dedhar, S ;
Pestell, RG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (42) :32649-32657
[8]   Characterization of a CREB gain-of-function mutant with constitutive transcriptional activity in vivo [J].
Du, KY ;
Asahara, H ;
Jhala, US ;
Wagner, BL ;
Montminy, M .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (12) :4320-4327
[9]   Cancer statistics, 2000 [J].
Greenlee, RT ;
Murray, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 2000, 50 (01) :7-33
[10]   Identification of c-MYC as a target of the APC pathway [J].
He, TC ;
Sparks, AB ;
Rago, C ;
Hermeking, H ;
Zawel, L ;
da Costa, LT ;
Morin, PJ ;
Vogelstein, B ;
Kinzler, KW .
SCIENCE, 1998, 281 (5382) :1509-1512